Free Trial

Stabilisation

SNAPSHOT

Below gives key levels of markets in the second half of the Asia-Pac session:

  • Nikkei 225 down 507.16 points at 28244.46
  • ASX 200 down 39.649 points at 7239.7
  • Shanghai Comp. down 12.577 points at 3551.512
  • JGB 10-Yr future up 7 ticks at 151.79, yield down 0.3bp at 0.071%
  • Aussie 10-Yr future down 0.5 ticks at 98.245, yield up 0.6bp at 1.742%
  • U.S. 10-Yr future -0-11 at 130-27, yield up 5.29bp at 1.526%
  • WTI crude up $2.71 at $70.86, Gold down $7.27 at $1795.34
  • USD/JPY up 2 pips at Y113.4
  • OMICRON CONTINUES TO SPREAD; BORDER RESTRICTIONS GET TIGHTENED
  • SOUTH AFRICAN DOCTOR SAYS PATIENTS WITH OMICRON VARIANT HAVE "VERY MILD" SYMPTOMS (RTRS)
  • MODERNA SAYS NEW VACCINE FOR OMICRON MAY BE READY IN EARLY 2022 (BBG)
  • PCRS DETECT OMICRON COVID-19 VARIANT, STUDIES UNDER WAY FOR OTHER TESTS (AFP)
  • WHO URGES CAUTION AS RESEARCHES RUSH TO LEARN MORE ABOUT OMICRON
  • LAGARDE, PANETTA SEE INFLATION SPIKE TIED TO TEMPORARY FACTORS

To read the full story

Close

Why MNI

MNI is the leading provider

of intelligence and analysis on the Global Fixed Income, Foreign Exchange and Energy markets. We use an innovative combination of real-time analysis, deep fundamental research and journalism to provide unique and actionable insights for traders and investors. Our "All signal, no noise" approach drives an intelligence service that is succinct and timely, which is highly regarded by our time constrained client base.

Our Head Office is in London with offices in Chicago, Washington and Beijing, as well as an on the ground presence in other major financial centres across the world.